What causes lung scarring in people with COVID-19?
Study code
NBR209
Lead researcher
Professor Michael Weekes
Study type
Samples and data
Institution or company
University of Cambridge
Researcher type
Academic
Speciality area
COVID
Summary
Since early in the pandemic it has been clear that COVID-19 can cause serious damage to the lungs. We know that in some patients, even when they have recovered from COVID-19 there is scarring in the lungs, which can cause the lungs to work less well. The more ill patients are with COVID-19 the higher the risk of scarring. Exactly what causes scarring in people with COVID-19 is unknown.
We have recently identified a protein that is released after virus infection. This protein is already known to cause scarring in various non-infectious diseases. Our study at the University of Cambridge will determine whether this protein causes lung scarring in people with COVID-19. Understanding this question may allow us to predict which COVID-19 patients are at risk of long term lung scarring. We can then try to develop drugs to prevent lung scarring. All data will be published rapidly in open-access journals, and there are no disclosure risks.
Participation: For this study we provided 100 stored serum samples from volunteers in the COVID-19 BioResource.
Organisation: This study is organised by Professor Michael Weekes from the University of Cambridge.